SOUTH SAN FRANCISCO, Calif., June 29, 2022 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (“Cytokinetics”) (Nasdaq: CYTK) today announced its intention to offer, subject to market and other conditions, $450.0 million aggregate principal amount of convertible senior notes due 2027 (the “notes”) in a private offering to qualified institutional buyers pursuant to […]
Author: Ken Dropiewski
BioSig Announces Closing of Public Offering of Common Stock
Westport, CT, June 29, 2022 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company advancing electrophysiology workflow by delivering greater intracardiac signal fidelity through its proprietary signal processing platform, today announced the closing and funding of its previously announced best efforts underwritten public […]
HeartBeam Expands Patient Population for Emergency Department Software Technology Solution
Expanded Scope of Clinical Validation Study Will Provide Access to a Broader Patient Population Company Expects to File 510K No Later Than August 15, 2022 SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology for heart attack detection, announced today […]
Hyperfine Names Scott Huennekens as Interim CEO
GUILFORD, Conn., June 29, 2022 (GLOBE NEWSWIRE) — Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created Swoop®, the world’s first FDA-cleared portable MRI system™, today announced that Dave Scott will step down from his role as President, Chief Executive Officer (CEO), and Board Member for personal reasons, effective July 29, 2022. Scott Huennekens, […]
Reflow Medical Completes DEEPER LIMUS Clinical Trial Enrollment
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Reflow Medical, Inc., a California-based medical device company, has completed enrollment in the DEEPER LIMUS clinical trial (NCT04162418) to evaluate the Temporary Spur Stent System, a patented device designed to treat long, diffuse and severely calcified infrapopliteal disease. The system allows for uniform expansion of the stent […]
Clarius Introduces Partnership with ImaCor That Powers New FDA Cleared Handheld Hemodynamic Ultrasound
Now made ultra-portable with Clarius, ImaCor’s Zura Handheld Hemodynamic Ultrasound™ has received FDA clearance as the world’s first handheld transesophageal echocardiography (TEE) system, enabling more clinicians to accurately determine appropriate interventions in real-time. VANCOUVER, BC and JERICHO, N.Y., June 29, 2022 /PRNewswire/ — Clarius Mobile Health, a leading provider of high-definition wireless ultrasound systems, and ImaCor Inc, […]
Humacyte Announces JAMA Surgery Publication Highlighting Potential of Human Acellular Vessel™ (HAV™) to Expand Vascular Trauma Reconstruction and Bypass Treatment Options
— HAV implanted in nearly 500 patients with more than 1,000 patient-years of follow up to date, for treatment of peripheral arterial disease, arteriovenous access for hemodialysis, and trauma – — Immediately-available HAV, if approved, would represent significant and innovative advancements for vascular repair and replacement conduits– DURHAM, N.C., June 29, […]
Nuwellis Announces First Patient Enrolled in its Pivotal Trial REVERSE-HF
REVERSE-HF will evaluate ultrafiltration therapy in comparison to IV diuretics to treat heart failure patients with fluid overload MINNEAPOLIS, June 29, 2022 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE) today announced the first patient has been enrolled in the company’s pivotal REVERSE-HF (Ultrafiltration Versus IV Diuretics in Worsening Heart Failure) clinical study. REVERSE-HF will evaluate […]
Windtree Is Leveraging Positive Istaroxime Early Cardiogenic Shock Results to Proactively Engage in Licensing Discussions and Explore Strategic Opportunities to Realize Greater Shareholder Value
Positive Data for Istaroxime in Early Cardiogenic Shock Brings Notable Interest from Potential Partners WARRINGTON, Pa., June 29, 2022 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interventions for acute cardiovascular disorders, today provided an update to its strategy and pursuit related to […]
Acticor Biotech Announces the Issuance of a Patent in Europe for Glenzocimab, Its Innovative Product for the Treatment of Cardiovascular Emergencies
This patent protects the use of glenzocimab in thrombotic diseases until 2036 This patent has already been granted in the United States and Singapore and is in the process of being granted in other countries such as Japan PARIS–(BUSINESS WIRE)–Regulatory News: ACTICOR BIOTECH (ISIN: FR0014005OJ5 – ALACT), a clinical-stage biotechnology […]
Recent
Popular
- No commented posts yet